Eplerenone Reduces Risk of Cardiovascular Failure in Diabetics | diabetes

Links shared publicly online about this topic.

  • 32
    total visits

Eplerenone Reduces Risk of Cardiovascular Failure in Diabetics | diabetes

diabeticlive.com

Eplerenone Reduces Risk of Cardiovascular Failure in Diabetics: The trial treated patients who had suffered NYHA class 2 systolic heart failure with eplerenone, an aldosterone blocker.

View full resource at diabeticlive.com

Tags: Heart, Heart Disease, Heart Failure, Diabetes

  • Share

Most Recently Shared on August 31, 2011 at 1:11 pm By:

diabeticlive diabeticlive

Eplerenone Reduces Risk of Cardiovascular Failure in Diabetics http://t.co/qiPh1gA

8 months ago...

Medical News: Glucose Control No Guarantee Against HF - in Cardiovascular, Diabetes from MedPage Today

medpagetoday.com — “For patients with type 2 diabetes, tight glycemic control does not reduce the risk of heart failure, according to a large meta-analysis.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on November 23, 2011 at 1:23 pm By:

ysijp Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist

For patients with type 2 #diabetes, tight glycemic control does not reduce the risk of heart failure http://t.co/FZMSlnMy

5 months ago...

Eplerenone Effective Across All High-Risk Heart Failure Patients : Internal Medicine News

internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice treView full resource at internalmedicinenews.com

  • View Related
  • Share

Most Recently Shared on August 29, 2011 at 7:18 pm By:

MedicalNewsNet Bob Finn - Medical News Net Health News

Eplerenone cut cardiovascular events significantly across all risk levels in patients with mild heart failure http://t.co/ElOI6Wp

8 months ago...

AHA: Eplerenone Reduced Mortality 24% in Mild Heart Failure : Internal Medicine News

internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice treView full resource at internalmedicinenews.com

  • View Related
  • Share

Most Recently Shared on November 15, 2010 at 8:04 pm By:

MedicalNewsNet Bob Finn - Medical News Net Health News

Eplerenone reduces mortality in mild heart failure by 24% in large study, @pwendl reports. http://bit.ly/dCVsKC

1 year ago...

Advertisement